BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37392242)

  • 1. The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients.
    Abdelgalil AA; Monir R; Elmetwally M; Ghattas MH; Bazeed FB; Mesbah NM; Abo-Elmatty DM; Mehanna ET
    Biochem Genet; 2024 Feb; 62(1):547-573. PubMed ID: 37392242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
    Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
    Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of genes involved in the hypoxia signaling pathway and the development of abdominal aortic aneurysms or large-artery atherosclerosis.
    Strauss E; Waliszewski K; Oszkinis G; Staniszewski R
    J Vasc Surg; 2015 May; 61(5):1105-13.e3. PubMed ID: 24657063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
    Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
    Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis.
    Madrid-Paredes A; Casado-Combreras MÁ; Pérez-Ramírez C; Segura-Pérez AM; Chamorro-Santos C; Vergara-Alcalde E; Sánchez-Pozo A; Calleja-Hernández MÁ; Cañadas-Garre M
    Pathol Res Pract; 2020 Apr; 216(4):152860. PubMed ID: 32127237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF A (rs699947 and rs833061) and VEGFR2 (rs2071559) gene polymorphisms are not associated with AMD susceptibility in a Spanish population.
    Cruz-González F; Cieza-Borrella C; Cabrillo-Estévez L; Cañete-Campos C; Escudero-Domínguez F; González-Sarmiento R
    Curr Eye Res; 2013 Dec; 38(12):1274-7. PubMed ID: 23971975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: A case-control study.
    Yu ZG; Wang BZ; Cheng ZZ
    Kaohsiung J Med Sci; 2017 Sep; 33(9):433-441. PubMed ID: 28865600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense Variants in Hypoxia-Induced VEGFA/VEGFR2 Signaling Predict the Outcome of Large Artery Atherosclerotic Stroke.
    Li Z; Wang M; Gu J; Zhao L; Guo Y; Zhang Z; Liu X
    Cell Mol Neurobiol; 2021 Aug; 41(6):1217-1225. PubMed ID: 32506171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Effects of Vascular Endothelial Growth Factor A (VEGF-A) and Its Association with Disease Progression in Breast Cancer Population of Saudi Arabia.
    Albalawi IA; Mir R; Abu Duhier FM
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):139-145. PubMed ID: 31983176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study about the association between vascular endothelial growth inhibitor gene polymorphisms and breast cancer risk in female patients in Northeast China.
    Han S; Liu L; Xu F; Chen S; Yuan W; Fu Z; Li D; Li D
    Chin J Cancer Res; 2016 Aug; 28(4):435-43. PubMed ID: 27647972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
    Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
    Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy.
    Kim DH; Xu W; Kamel-Reid S; Liu X; Jung CW; Kim S; Lipton JH
    Ann Oncol; 2010 Jun; 21(6):1179-1188. PubMed ID: 19875757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HIF1A, VEGFA and VEGFR2 SNPs in the Susceptibility and Progression of COPD in a Spanish Population.
    Baz-Dávila R; Espinoza-Jiménez A; Rodríguez-Pérez Mdel C; Zulueta J; Varo N; Montejo Á; Almeida-González D; Aguirre-Jaime A; Córdoba-Lanús E; Casanova C
    PLoS One; 2016; 11(5):e0154998. PubMed ID: 27163696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of
    Islam MS; Jesmin
    JCO Glob Oncol; 2022 Mar; 8():e2100399. PubMed ID: 35507894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).
    Hagstrom SA; Ying GS; Pauer GJ; Sturgill-Short GM; Huang J; Maguire MG; Martin DF;
    JAMA Ophthalmol; 2014 May; 132(5):521-7. PubMed ID: 24652518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease.
    Liu D; Song J; Ji X; Liu Z; Cong M; Hu B
    Medicine (Baltimore); 2016 May; 95(19):e3413. PubMed ID: 27175642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor single nucleotide polymorphisms and haplotypes in pre-eclampsia: A case-control study.
    Ben Ali Gannoun M; Al-Madhi SA; Zitouni H; Raguema N; Meddeb S; Hachena Ben Ali F; Mahjoub T; Almawi WY
    Cytokine; 2017 Sep; 97():175-180. PubMed ID: 28651127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of genes involved in the angiogenesis-associated signaling pathway with risk of anterior cruciate ligament rupture.
    Rahim M; Gibbon A; Hobbs H; van der Merwe W; Posthumus M; Collins M; September AV
    J Orthop Res; 2014 Dec; 32(12):1612-8. PubMed ID: 25111568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
    Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of VEGFA variants with altered VEGF secretion and type 2 diabetes: A case-control study.
    Sellami N; Lamine LB; Turki A; Sarray S; Jailani M; Al-Ansari AK; Ghorbel M; Mahjoub T; Almawi WY
    Cytokine; 2018 Jun; 106():29-34. PubMed ID: 29533820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.